User menu

Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.

Bibliographic reference Van Roosbroeck, Katrien ; Ferreiro, Julio Finalet ; Tousseyn, Thomas ; van der Krogt, Jo-Anne ; Michaux, Lucienne ; et. al. Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.. In: Genes, Chromosomes & Cancer, Vol. 55, no.5, p. 428-441 (2016)
Permanent URL http://hdl.handle.net/2078.1/173195
  1. Andorsky D. J., Yamada R. E., Said J., Pinkus G. S., Betting D. J., Timmerman J. M., Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells, 10.1158/1078-0432.ccr-10-2660
  2. Ansell Stephen M., Lesokhin Alexander M., Borrello Ivan, Halwani Ahmad, Scott Emma C., Gutierrez Martin, Schuster Stephen J., Millenson Michael M., Cattry Deepika, Freeman Gordon J., Rodig Scott J., Chapuy Bjoern, Ligon Azra H., Zhu Lili, Grosso Joseph F., Kim Su Young, Timmerman John M., Shipp Margaret A., Armand Philippe, PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma, 10.1056/nejmoa1411087
  3. Armand, Blood, 125, 393 (2015)
  4. Bentz Martin, Barth Thomas F. E., Br�derlein Silke, Bock Daliah, Schwerer Michael J., Baudis Michael, Joos Stefan, Viardot Andreas, Feller Alfred C., M�ller-Hermelink Hans-Konrad, Lichter Peter, D�hner Hartmut, M�ller Peter, Gain of chromosome arm 9p is characteristic of primary mediastinal b-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line, 10.1002/1098-2264(2001)9999:9999<::aid-gcc1105>3.0.co;2-i
  5. Berghoff Anna Sophie, Ricken Gerda, Widhalm Georg, Rajky Orsolya, Hainfellner Johannes A., Birner Peter, Raderer Markus, Preusser Matthias, PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL), 10.5414/np300698
  6. Berry W. L., Janknecht R., KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells, 10.1158/0008-5472.can-12-4300
  7. Blank Christian, Mackensen Andreas, Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion, 10.1007/s00262-006-0272-1
  8. Chen B. J., Chapuy B., Ouyang J., Sun H. H., Roemer M. G. M., Xu M. L., Yu H., Fletcher C. D. M., Freeman G. J., Shipp M. A., Rodig S. J., PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies, 10.1158/1078-0432.ccr-13-0855
  9. Chin Young-Won, Han Sun-Young, KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review, 10.1517/13543776.2014.991310
  10. De Keersmaecker K., Michaux L., Bosly A., Graux C., Ferreiro J. F., Vandenberghe P., Cools J., Wlodarska I., Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL, 10.1182/blood-2011-10-388124
  11. Finalet Ferreiro, Am J Transplant
  12. Ghoreschi Kamran, Laurence Arian, O’Shea John J., Janus kinases in immune cell signaling, 10.1111/j.1600-065x.2008.00754.x
  13. Green M. R., Monti S., Rodig S. J., Juszczynski P., Currie T., O'Donnell E., Chapuy B., Takeyama K., Neuberg D., Golub T. R., Kutok J. L., Shipp M. A., Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma, 10.1182/blood-2010-05-282780
  14. Hao Y., Chapuy B., Monti S., Sun H. H., Rodig S. J., Shipp M. A., Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo, 10.1158/1078-0432.ccr-13-3007
  15. Joos, Cancer Res, 60, 549 (2000)
  16. Kawamura Machiko, Taki Tomohiko, Kaku Hidefumi, Ohki Kentaro, Hayashi Yasuhide, Identification ofSPAG9as a novelJAK2fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21) : ALL WITH SPAG-JAK2 FUSION AND IKZF1 DELETION, 10.1002/gcc.22251
  17. Keir Mary E., Butte Manish J., Freeman Gordon J., Sharpe Arlene H., PD-1 and Its Ligands in Tolerance and Immunity, 10.1146/annurev.immunol.26.021607.090331
  18. Küppers Ralf, Dalla-Favera Riccardo, Mechanisms of chromosomal translocations in B cell lymphomas, 10.1038/sj.onc.1204640
  19. Lahortiga Idoya, De Keersmaecker Kim, Van Vlierberghe Pieter, Graux Carlos, Cauwelier Barbara, Lambert Frederic, Mentens Nicole, Beverloo H Berna, Pieters Rob, Speleman Frank, Odero Maria D, Bauters Marijke, Froyen Guy, Marynen Peter, Vandenberghe Peter, Wlodarska Iwona, Meijerink Jules P P, Cools Jan, Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia, 10.1038/ng2025
  20. Li Yi, Wang Jing, Li Chong, Ke Xiao-Yan, Contribution of PD-L1 to oncogenesis of lymphoma and its RNAi-based targeting therapy, 10.3109/10428194.2012.673228
  21. Martín-Subero J I, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, Calasanz M J, De Wolf-Peeters C, Dyer M J, Felman P, Gardiner A, Gascoyne R D, Gesk S, Harder L, Horsman D E, Kneba M, Küppers R, Majid A, Parry-Jones N, Ritgen M, Salido M, Solé F, Thiel G, Wacker H-H, Oscier D, Wlodarska I, Siebert R, A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation, 10.1038/sj.leu.2404695
  22. McPherson Andrew, Hormozdiari Fereydoun, Zayed Abdalnasser, Giuliany Ryan, Ha Gavin, Sun Mark G. F., Griffith Malachi, Heravi Moussavi Alireza, Senz Janine, Melnyk Nataliya, Pacheco Marina, Marra Marco A., Hirst Martin, Nielsen Torsten O., Sahinalp S. Cenk, Huntsman David, Shah Sohrab P., deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data, 10.1371/journal.pcbi.1001138
  23. Meier Cecile, Hoeller Sylvia, Bourgau Caroline, Hirschmann Petra, Schwaller Juerg, Went Philip, Pileri Stefano A, Reiter Andreas, Dirnhofer Stephan, Tzankov Alexandar, Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas, 10.1038/modpathol.2008.207
  24. Melzner I., Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line, 10.1182/blood-2004-09-3701
  25. Put Natalie, , Van Roosbroeck Katrien, Konings Peter, Meeus Peter, Brusselmans Caroline, Rack Katrina, Gervais Carine, Nguyen-Khac Florence, Chapiro Elise, Radford-Weiss Isabelle, Struski Stéphanie, Dastugue Nicole, Gachard Nathalie, Lefebvre Christine, Barin Carole, Eclache Virginie, Fert-Ferrer Sandra, Laibe Sophy, Mozziconacci Marie-Joëlle, Quilichini Benoît, Poirel Hélène A., Wlodarska Iwona, Hagemeijer Anne, Moreau Yves, Vandenberghe Peter, Michaux Lucienne, Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course, 10.1007/s00277-011-1393-y
  26. Rouhigharabaei Leila, Ferreiro Julio Finalet, Put Natalie, Michaux Lucienne, Tousseyn Thomas, Lefebvre Christine, Gardiner Anne, De Kelver Wim, Demuynck Hilde, Verschuere Johan, Théate Ivan, Vicente Carmen, Vandenberghe Peter, Cools Jan, Wlodarska Iwona, BMI1, The polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma : BMI1Aberrations in B-Cell Leukemia/Lymphoma, 10.1002/gcc.22088
  27. Rui Lixin, Emre N.C. Tolga, Kruhlak Michael J., Chung Hye-Jung, Steidl Christian, Slack Graham, Wright George W., Lenz Georg, Ngo Vu N., Shaffer Arthur L., Xu Weihong, Zhao Hong, Yang Yandan, Lamy Laurence, Davis R. Eric, Xiao Wenming, Powell John, Maloney David, Thomas Craig J., Möller Peter, Rosenwald Andreas, Ott German, Muller-Hermelink Hans Konrad, Savage Kerry, Connors Joseph M., Rimsza Lisa M., Campo Elias, Jaffe Elaine S., Delabie Jan, Smeland Erlend B., Weisenburger Dennis D., Chan Wing C., Gascoyne Randy D., Levens David, Staudt Louis M., Cooperative Epigenetic Modulation by Cancer Amplicon Genes, 10.1016/j.ccr.2010.11.013
  28. Shaffer, An International System for Human Cytogenetic Nomenclature (2013) (2013)
  29. Sharma Padmanee, Wagner Klaus, Wolchok Jedd D., Allison James P., Novel cancer immunotherapy agents with survival benefit: recent successes and next steps, 10.1038/nrc3153
  30. Skoda Radek C., Duek Adrian, Grisouard Jean, Pathogenesis of myeloproliferative neoplasms, 10.1016/j.exphem.2015.06.007
  31. Springuel L., Renauld J.-C., Knoops L., JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications, 10.3324/haematol.2015.132142
  32. Steidl Christian, Shah Sohrab P., Woolcock Bruce W., Rui Lixin, Kawahara Masahiro, Farinha Pedro, Johnson Nathalie A., Zhao Yongjun, Telenius Adele, Neriah Susana Ben, McPherson Andrew, Meissner Barbara, Okoye Ujunwa C., Diepstra Arjan, van den Berg Anke, Sun Mark, Leung Gillian, Jones Steven J., Connors Joseph M., Huntsman David G., Savage Kerry J., Rimsza Lisa M., Horsman Douglas E., Staudt Louis M., Steidl Ulrich, Marra Marco A., Gascoyne Randy D., MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers, 10.1038/nature09754
  33. Twa David D. W., Chan Fong Chun, Ben-Neriah Susana, Woolcock Bruce W., Mottok Anja, Tan King L., Slack Graham W., Gunawardana Jay, Lim Raymond S., McPherson Andrew W., Kridel Robert, Telenius Adele, Scott David W., Savage Kerry J., Shah Sohrab P., Gascoyne Randy D., Steidl Christian, Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma, 10.1182/blood-2013-10-535443
  34. Twa David DW, Mottok Anja, Chan Fong Chun, Ben-Neriah Susana, Woolcock Bruce W, Tan King L, Mungall Andrew J, McDonald Helen, Zhao Yongjun, Lim Raymond S, Nelson Brad H, Milne Katy, Shah Sohrab P, Morin Ryan D, Marra Marco A, Scott David W, Gascoyne Randy D, Steidl Christian, Recurrent genomic rearrangements in primary testicular lymphoma : Genomic rearrangements in primary testicular lymphoma, 10.1002/path.4522
  35. Twa David D. W., Steidl Christian, Structural genomic alterations in primary mediastinal large B-cell lymphoma, 10.3109/10428194.2014.985673
  36. Vainchenker William, Dusa Alexandra, Constantinescu Stefan N., JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficiencies, 10.1016/j.semcdb.2008.07.002
  37. Van Roosbroeck K., Cox L., Tousseyn T., Lahortiga I., Gielen O., Cauwelier B., De Paepe P., Verhoef G., Marynen P., Vandenberghe P., De Wolf-Peeters C., Cools J., Wlodarska I., JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma, 10.1182/blood-2010-06-291310
  38. Vandenberghe Peter, Wlodarska Iwona, Tousseyn Thomas, Dehaspe Luc, Dierickx Daan, Verheecke Magali, Uyttebroeck Anne, Bechter Oliver, Delforge Michel, Vandecaveye Vincent, Brison Nathalie, Verhoef Gregor EG, Legius Eric, Amant Frederic, Vermeesch Joris R, Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study, 10.1016/s2352-3026(14)00039-8
  39. Vinatzer U., Gollinger M., Mullauer L., Raderer M., Chott A., Streubel B., Mucosa-Associated Lymphoid Tissue Lymphoma: Novel Translocations Including Rearrangements of ODZ2, JMJD2C, and CNN3, 10.1158/1078-0432.ccr-08-0702
  40. Willis, Blood, 96, 808 (2000)
  41. Zou Weiping, Chen Lieping, Inhibitory B7-family molecules in the tumour microenvironment, 10.1038/nri2326